MAPK3 and breast cancer: Filardo et al. found that estrogen can activate the activity of Erk1/2 in breast cancer 4 cells in breast cancer cells that only express GPER1 and do not express estrogen nuclear receptors, which makes the relationship between GPR30 and estrogen begin to be paid attention to [26].